Seeking Alpha

More on GlaxoSmithKline (GSK +0.1%) Q3: Misses on revenue and EPS; core operating profit -15% to...

More on GlaxoSmithKline (GSK +0.1%) Q3: Misses on revenue and EPS; core operating profit -15% to £1.97B. Earnings hurt by "demanding prior year comparisons" and continued weakness in Europe, where sales fell 9% as price pressure takes a toll. U.S. sales -6%, "reflecting genericisation and discontinuation of certain products." (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)